Impact of physicians beliefs and practices on cholesterol levels in patients with type 2 diabetes: A longitudinal assessment

被引:7
作者
Franciosi, M
Pellegrini, F
De Berardis, G
Belfiglio, M
Di Nardo, B
Greenfield, S
Kaplan, SH
Rossi, MCE
Sacco, M
Tognoni, G
Valentini, M
Nicolucci, A
机构
[1] Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, I-66030 Santa Maria Imbaro, Italy
[2] Univ Calif Irvine, Ctr Hlth Policy Res, Irvine, CA USA
关键词
D O I
10.1016/j.ahj.2004.06.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Clinical trials demonstrate significant benefit from cholesterol management for patients with type 2 diabetes. The aim of this work was to explore the correlates of lipid management in patients with type 2 diabetes, including the subjective beliefs of physicians, setting of care, and patient-related factors. Methods This longitudinal outcomes research study involved 2359 patients with type 2 diabetes recruited by I I I general practitioners and 214 physicians practicing in diabetes clinics. Physicians' beliefs were assessed through a questionnaire administered when the study started in 1998., Main outcome measures were total cholesterol (TC) and LDL cholesterol (LDL-C) levels over 3 years and the proportion of patients treated with lipid-lowering drugs (LLDs). Results Less than one-third of the physicians (27%) stated that they routinely started pharmacologic therapy for TC values greater than or equal to200 mg/dL (more aggressive), whereas 46% considered a TC level greater than or equal to240 mg/dL as the threshold for the initiation of treatment (less aggressive). During 3 years of observation,. mean TC and LDL-C levels decreased from 2 15 +/- 40 mg/dL to 203 +/- 37 mg/dL and from 135 +/- 36 mg/dL to 126 +/- 35 mg/dL respectively, while the proportion of patients treated with LLPs increased from 13.2% to 24.6%; in particular, among individuals cared for by the more aggressive physicians, 30.0% were taking LLDs after 3 years, while only 17.7% of those followed by the less aggressive physicians and 18.1 % of those followed by > 1 physician were being treated with LLDs. Multilevel analysis showed that physicians' beliefs were an independent predictor of TC levels over the 3-year period. In patients treated with LLDs, TC levels decreased on average by 14%, and LDL-C levels decreased by 20%. Conclusion Our data show that physicians' beliefs in more aggressive management strategies will result in better mean TC values over a 3-year period.
引用
收藏
页码:104 / 110
页数:7
相关论文
共 30 条
[21]   Cardiovascular disease prevention practices by US physicians for patients with diabetes [J].
Meigs, JB ;
Stafford, RS .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2000, 15 (04) :220-228
[22]   Impact of diabetes on mortality after the first myocardial infarction [J].
Miettinen, H ;
Lehto, S ;
Salomaa, V ;
Mähönen, M ;
Niemelä, M ;
Haffner, SM ;
Pyörälä, K ;
Tuomilehto, J .
DIABETES CARE, 1998, 21 (01) :69-75
[23]   Role of organizational factors in poor blood pressure control in patients with type 2 diabetes - The QuED study group - Quality of care and outcomes in type 2 diabetes [J].
Pellegrini, F ;
Belfiglio, M ;
De Berardis, G ;
Franciosi, M ;
Di Nardo, B ;
Greenfield, S ;
Kaplan, SH ;
Sacco, M ;
Tognoni, G ;
Valentini, M ;
Corrado, D ;
D'Ettorre, A ;
Nicolucci, A .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (04) :473-480
[24]   Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease - A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) [J].
Pyorala, K ;
Pedersen, TR ;
Kjekshus, J ;
Faergeman, O ;
Olsson, AG ;
Thorgeirsson, G .
DIABETES CARE, 1997, 20 (04) :614-620
[25]  
Pyorala K, 1997, DIABETES CARE, V20, P1048
[26]  
SNIJDERS T, 1999, SAGE PUBLICATIONS
[27]   DIABETES, OTHER RISK-FACTORS, AND 12-YR CARDIOVASCULAR MORTALITY FOR MEN SCREENED IN THE MULTIPLE RISK FACTOR INTERVENTION TRIAL [J].
STAMLER, J ;
VACCARO, O ;
NEATON, JD ;
WENTWORTH, D .
DIABETES CARE, 1993, 16 (02) :434-444
[28]  
Sullivan LM, 1999, STAT MED, V18, P855, DOI 10.1002/(SICI)1097-0258(19990415)18:7<855::AID-SIM117>3.0.CO
[29]  
2-7
[30]  
Wood D, 1998, EUR HEART J, V19, P1434